PMDA drug package insert
ボルタレンEXスプレー
PMDA OTC drug · グラクソ・スミスクライン・コンシューマー・ヘルスケア・ジャパン（株） · package insert May 13, 2023
Key facts
| Brand names | ボルタレンEXスプレー |
|---|---|
| Companies | 製造販売元／同仁医薬化工（株）,販売会社／グラクソ・スミスクライン・コンシューマー・ヘルスケア・ジャパン（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 噴霧剤 |
| OTC effect category | 鎮痛・鎮痒・収れん・消炎薬（パップ剤を含む） |
| Package insert date | May 13, 2023 |
| PMDA document key | 471825_J1401000230 |
| PMDA company code | 471825 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: